Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Treanor

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Vaccine|March 20, 2010
Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunizationJessica L Halliley, Shuya Kyu, James J Kobie, et al.
Vaccine|May 22, 2013
Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and olderLisa A Jackson, Alejandra Gurtman, Martin van Cleeff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adultsJames D Cherry, Swei-Ju Chang, David Klein, et al.
The New England Journal of Medicine|October 14, 2005
Efficacy of an acellular pertussis vaccine among adolescents and adultsJoel I Ward, James D Cherry, Swei-Ju Chang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2006
Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT)Joel I Ward, James D Cherry, Swei-Ju Chang, et al.
Vaccine|October 7, 2014
Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines?James G Donahue, Burney A Kieke, Peter G Szilagy, et al.
Pediatrics|October 3, 2002
Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged childrenPedro A Piedra, Lihan Yan, Karen Kotloff, et al.
The Journal of Infectious Diseases|June 30, 2016
Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental ChallengeSinthujan Jegaskanda, Catherine Luke, Heather D Hickman, et al.
The Oncologist|January 14, 2012
Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancerYiqing Xu, Nanda Methuku, Praveena Coimbatore, et al.
The Journal of Infectious Diseases|July 10, 2004
Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT StudyThuan Le, James D Cherry, Swei-Ju Chang, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Vaccine|March 20, 2010
Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunizationJessica L Halliley, Shuya Kyu, James J Kobie, et al.
Vaccine|May 22, 2013
Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and olderLisa A Jackson, Alejandra Gurtman, Martin van Cleeff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adultsJames D Cherry, Swei-Ju Chang, David Klein, et al.
The New England Journal of Medicine|October 14, 2005
Efficacy of an acellular pertussis vaccine among adolescents and adultsJoel I Ward, James D Cherry, Swei-Ju Chang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2006
Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT)Joel I Ward, James D Cherry, Swei-Ju Chang, et al.
Vaccine|October 7, 2014
Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines?James G Donahue, Burney A Kieke, Peter G Szilagy, et al.
Pediatrics|October 3, 2002
Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged childrenPedro A Piedra, Lihan Yan, Karen Kotloff, et al.
The Journal of Infectious Diseases|June 30, 2016
Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental ChallengeSinthujan Jegaskanda, Catherine Luke, Heather D Hickman, et al.
The Oncologist|January 14, 2012
Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancerYiqing Xu, Nanda Methuku, Praveena Coimbatore, et al.
The Journal of Infectious Diseases|July 10, 2004
Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT StudyThuan Le, James D Cherry, Swei-Ju Chang, et al.
Pageof 6